Virtu Financial LLC purchased a new stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 9,422 shares of the company’s stock, valued at approximately $1,632,000.
Several other hedge funds and other institutional investors have also bought and sold shares of PG. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble in the second quarter valued at approximately $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble in the second quarter valued at $29,000. RPg Family Wealth Advisory LLC purchased a new position in shares of Procter & Gamble during the 3rd quarter valued at $33,000. POM Investment Strategies LLC bought a new position in shares of Procter & Gamble during the 2nd quarter worth $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble during the second quarter valued at about $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the transaction, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. This represents a 2.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 83,080 shares of company stock worth $14,629,038. 0.18% of the stock is currently owned by corporate insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 EPS. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. As a group, equities analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.
Wall Street Analysts Forecast Growth
PG has been the subject of several recent research reports. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. DA Davidson upgraded shares of Procter & Gamble from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $160.00 to $209.00 in a research note on Monday, November 25th. Evercore ISI increased their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. JPMorgan Chase & Co. boosted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Finally, Morgan Stanley raised their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus target price of $180.45.
View Our Latest Analysis on Procter & Gamble
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- How to Buy Cheap Stocks Step by Step
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Following Congress Stock Trades
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Stock Analyst Ratings and Canadian Analyst Ratings
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.